Dow Mark A. 4
4 · KV PHARMACEUTICAL CO /DE/ · Filed Sep 12, 2011
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA/KVB
Dow Mark A.
Director
Transactions
- Award
Option to Purchase
2011-09-08+20,000→ 20,000 totalExercise: $1.49Exp: 2021-09-08→ Class A Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal installments beginning September 8, 2012.